Ai Advantage

Servatus is an Australian biopharmaceutical company based in Brisbane City, focused on developing innovative dual drug platforms for treating autoimmune inflammatory and infectious conditions. Their research includes the isolation and characterization of select microbial species to create live biotherapeutics, which are currently undergoing human clinical trials to assess their clinical utility. The company aims to advance medical therapies by harnessing new modes of action, particularly through engineered proteins that enhance treatment efficacy and safety for patients with immune-mediated inflammatory diseases. Servatus is committed to improving therapeutic outcomes and complementing existing drug therapies with their cutting-edge research in live biotherapeutic agents derived from microorganisms. Generated from the website